RxDoctor Payments Data

Gregory Maynard, DO

Family Medicine · Salem, MONPI 1063450187

Payments from drug & device makers

$10,915in general payments, 2019–2025

Across 788 payments — averaging $13.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Amgen$997
  • GSK$916
  • Lilly USA, LLC$895
  • Novo Nordisk$827
  • plus $5K from 35 others

What the payments were for

  • Food & beverage$10,884100%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,915 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$23,157
Medicare patients
160
Services billed
1,556

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban237$189,640
Humira(Cf) PenAdalimumab12$166,983
JardianceEmpagliflozin136$131,968
MounjaroTirzepatide96$115,873
OzempicSemaglutide71$87,226
RybelsusSemaglutide65$80,537
LinzessLinaclotide98$79,655
Trelegy ElliptaFluticasone/Umeclidin/Vilanter111$78,402
FarxigaDapagliflozin Propanediol94$75,453
Repatha SureclickEvolocumab111$64,805
EntrestoSacubitril/Valsartan50$61,563
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr81$43,822
Breztri AerosphereBudesonide/Glycopyr/Formoterol62$42,852
TrulicityDulaglutide31$35,869
VascepaIcosapent Ethyl90$35,251

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Lyrica, Nurtec Odt$661$219,565270 claims
Novo NordiskOzempic, Rybelsus$827$167,764136 claims
Lilly USA, LLCMounjaro, Trulicity$895$151,742127 claims
Boehringer IngelheimJardiance, Combivent Respimat$401$141,473150 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$916$137,244227 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,038$128,430192 claims
AbbVieLinzess, Vraylar$1,291$107,200114 claims
NovartisEntresto$165$61,56350 claims
BayerKerendia$401$29,83022 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$482$28,95933 claims
MerckJanuvia$402$25,45822 claims
Johnson & JohnsonXarelto$147$23,97424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Salem

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →